CAChristopher A. Adin

Christopher A. Adin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christopher A. Adin has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • A. Kenzig

    Department of Veterinary Clinical Sciences and Surgery, The Ohio State University, Columbus, OH 43210, USA

    1 shared publication
  • A. Rajab

    Department of Surgery, The Ohio State University, Columbus, OH 43210, USA

    1 shared publication
  • Amer Rajab

    Department of Veterinary Clinical Sciences Ohio State University Columbus Ohio

    1 shared publication
  • Andrew Marsh

    Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, OH 43210, USA

    1 shared publication
  • Brian A. Scansen

    College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Clinical Sciences Fort Collins, Colorado

    1 shared publication
  • C. Gilor

    Department of Veterinary Clinical Sciences and Surgery, The Ohio State University, Columbus, OH 43210, USA

    1 shared publication

Latest Publications

  • Pancreatic Islet Transplantation: From Dogs to Humans and Back Again

    by Daniela Vrabelova, Christopher Adin, Chen Gilor, Amer Rajab

    Pancreatic islet transplantation is a cell-based therapy that provides a potential cure for type 1 diabetes mellitus. After the introduction of an automated method for islet isolation and steroid-free immunosuppressive protocols, reversal of diabetes by islet transplantation is now performed at major human medical centers around the world. Despite extensive use of animal models in islet transplantation research, practical concerns have slowed the introduction of the technique into clinical veterinary practice and only a small number of studies have reported results of transplantation in dogs with spontaneously occurring diabetes mellitus; however, recent advances in islet isolation and encapsulation may make it possible to perform islet transplantation without immunosuppression in companion animals. This review summarizes experimental and clinical studies of pancreatic islet transplantation in dogs, including future directions for cell therapy in animals with naturally occurring disease.


  • Suture-Free Technique for Canine Ureteral Resection-Anastomosis Using a Microvascular Anastomotic System: A Cadaveric Study

    by Vincent Wavreille, Christopher A. Adin, Johnattan Arango, Kathleen L. Ham, Julie K. Byron, Mary A. McLoughlin

    To describe a suture-free technique for canine ureteral resection-anastomosis using a microvascular anastomotic system (MAS) and to compare surgical time and burst pressure of hand-sewn (HS) ureteral end-to-end anastomosis with the MAS technique. Experimental ex vivo study. Canine cadavers (n = 8). For each cadaver, 1 ureter was randomly assigned to undergo HS anastomosis and the contralateral ureter had MAS anastomosis. The first 3 cadavers (6 ureters) were used to refine the MAS technique. In the other 5 dogs, surgical time and ureteral burst pressure were compared between groups (n = 5 ureters/group). Preliminary procedures showed that selective impaling of the mucosa and submucosa (without muscularis and adventitia) is necessary to allow complete mechanical interlock of the anastomotic rings for the MAS technique. Median anastomotic time was significantly shorter for MAS (7.6 min) than HS (16.6 min; p = .029) and burst pressure higher for MAS (393 cm H2 O) than HS (180 cm H2 O; p = .012). This study demonstrated the feasibility of a suture-free technique of canine ureteral resection-anastomosis using a commercially available MAS. The MAS anastomosis was faster and had higher burst strength compared with the HS anastomosis.


  • Open Access

    Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia/reperfusion model

    by Ron Ben-Amotz, John Bonagura, Murugesan Velayutham, Robert Hamlin, Patrick Burns, Christopher Adin

    Bilirubin was previously considered a toxin byproduct of heme catabolism. However, a mounting body of evidence suggests that at physiological doses, bilirubin is a powerful antioxidant and anti-atherosclerotic agent. Recent clinical studies have shown that human beings with genetically-induced hyperbilirubinemia (Gilbert Syndrome) are protected against coronary heart disease. The purpose of this study was to investigate whether administration of exogenous bilirubin to normal rats would convey similar protective effects in an experimental model of coronary ischemia. We hypothesized that intraperitoneal bilirubin administration 1 hour before injury would decrease infarct area and preserve left ventricular (LV) systolic function when compared to non-treated rats. Coronary ischemia was induced by temporary (30 min) ligation of the left anterior descending coronary artery in control or bilirubin treated rats, followed by a 1-hour period of reperfusion. LV function was estimated by measurements of fractional shortening and fractional area shortening using echocardiography. LV function decreased in both experimental groups after ischemia and reperfusion, although in bilirubin-treated rats fractional shortening was less depressed during the period of ischemia (18.8 vs 25.8%, p = 0.034). Infarct size was significantly reduced in the bilirubin treated group compared to the non-treated group (13.34% vs 25.5%, p = 0.0067). Based on the results of this study, bilirubin supplementation appears to provide significant decrease in infarct size although protective effects on LV function were noted only during the period of ischemia. This result also suggests that lipid soluble antioxidant bilirubin prevents the oxidation of cardiolipin and decreases the infarct size in the heart during ischemia.


  • Tunneling Under the Digastricus Muscle Increases Salivary Duct Exposure and Completeness of Excision in Mandibular and Sublingual Sialoadenectomy in Dogs

    by Andrew Marsh, Christopher Adin

    Objective: To document the extent of rostral salivary duct and glandular tissue excision achieved through a conventional lateral approach before and after tunneling under the digastricus muscle.Study Design: Experimental cadaveric study.Animals: Dog cadavers (n = 8).Methods: Bilateral mandibular and sublingual sialoadenectomy was performed in 8 cadavers using a conventional lateral approach and the point of proposed salivary duct transection was marked with Evans blue dye. Remaining salivary duct was then tunneled under the digastricus muscle and dissection continued rostrally. The most rostral point of the gland/duct complex was marked before transection of the salivary duct. Once removed, the distance between the 2 marks was measured and recorded. Completeness of glandular tissue excision was confirmed by dissection and gross examination.Results: The tunneling technique improved rostral exposure and increased the median (IQR) length of salivary duct excision by 1.8 (0.35) cm. Residual polystomatic sublingual salivary tissue remained in all cadavers after simulated resection without tunneling under the digastricus muscle. After tunneling, complete removal of rostral salivary tissue was achieved in 13 of 15 procedures.Conclusions: Tunneling under the digastricus muscle increases the length of rostral salivary duct and glandular tissue that can be removed through a conventional lateral approach.


  • Outcome after Placement of an Artificial Urethral Sphincter in 27 Dogs

    by Lauren Reeves, Christopher Adin, Mary McLoughlin, Kathleen Ham, Dennis Chew

    Objective: To evaluate the safety and efficacy of an adjustable artificial urethral sphincter (AUS) in a population of dogs with acquired or congenital urinary incontinence.Study Design: Case series.Animals: Dogs (n = 27) with naturally occurring urinary incontinence.Methods: Medical records (January 2009–July 2011) of dogs that hadAUSimplantation for treatment of urinary incontinence were reviewed and owners were interviewed by telephone to assess outcome. Continence was scored using a previously established analogue scale, with 1 representing constant leakage and 10 representing complete continence.Results: Twenty‐four female and 3 male dogs hadAUSimplantation. Causes of incontinence included urethral sphincter mechanism incompetence (n = 18), continued incontinence after ectopic ureter repair (6), and pelvic bladder (3). Medical therapy was unsuccessful in 25 dogs beforeAUSimplantation. Surgery was performed without major complications in 25 dogs; 2 developed partial urethral obstruction after 5 and 9 months. Median (interquartile range) follow‐up for the other 25 dogs was 12.5 (6–19) months. Continence scores were significantly improved (P< .0001) between the preoperative period (2 [1–4]) and last follow‐up (9 [8–10]). Overall, 22 owners described themselves as very satisfied, 2 as satisfied, and 3 as unsatisfied.Conclusions: AUSimplantation was successful in restoring continence in male and female dogs with both congenital and acquired urinary incontinence. Dogs that develop partial urethral obstruction may requireAUSremoval.


  • Bladder inversion and secondary hematuria in a 6-month-old domestic shorthair cat

    by Christopher A. Adin, Dennis J. Chew, Hock Gan Heng, Katy L. Townsend, Ketaki Karnik

    Case Description—A 6-month-old female domestic shorthair cat was admitted for evaluation of intermittent clinical signs of hematuria and inappropriate urination for the past 2 months. Clinical Findings—Transabdominal ultrasonography revealed a multilayered mass in the urinary bladder apex consistent with full-thickness invagination of the bladder wall. Treatment and Outcome—Exploratory surgery was performed, and partial inversion of the urinary bladder was confirmed. The invaginated bladder apex was manually reduced, and partial cystectomy was performed to remove the invaginated section of bladder wall. Histologic findings were consistent with vascular congestion and edema secondary to partial invagination. Bacterial culture of a section of the bladder mucosa demonstrated concurrent bacterial urinary tract infection. Clinical signs resolved following surgical resection of the bladder apex and antimicrobial treatment for the concurrent urinary tract infection. Clinical Relevance—Partial invagination of the urinary bladder should be considered in the differential diagnosis for cats with clinical signs of hematuria, stranguria, and inappropriate urination. A diagnosis may be made on the basis of detection of invaginated tissue in the bladder apex during abdominal ultrasonography.


  • Long‐Term Efficacy of a Percutaneously Adjustable Hydraulic Urethral Sphincter for Treatment of Urinary Incontinence in Four Dogs

    by Scott A. Rose, Christopher A. Adin, Gary W. Ellison, Colin W. Sereda, Linda L. Archer

    Objective—To evaluate the efficacy of a surgically placed, static hydraulic urethral sphincter (SHUS) for treatment of urethral sphincter mechanism incompetency (USMI).Study Design—Prospective study.Animals—Spayed female dogs (n=4) with acquired USMI.Methods—Urinary incontinence was assessed using a subjective continence score before and after implantation of an SHUS on the proximal urethra via ventral median celiotomy. Dogs were assessed for urinary continence, urinary tract infections, and implant‐associated complications for 30 months. Residual incontinence was treated with percutaneous inflation of the SHUS with sterile saline solution through a biocompatible subcutaneous administration port.Results—At last follow‐up (26–30 months after surgery), continence scores improved from a median preoperative score of 3/10 to a median postoperative score of 10. One dog developed wound drainage over the subcutaneously placed administration port but remained continent after port removal. Three occluders were percutaneously filled with additional saline (median, 0.18 mL; mean, 0.16 mL) to improve continence after surgery.Conclusions—Application and adjustment of an SHUS provided sustained improvements in continence score in all dogs.Clinical Relevance—In this pilot study, 3 of 4 dogs with hydraulic urethral sphincter implantation had successful percutaneous adjustment and maintained improved continence scores for 2 years after surgery. Continence was maintained in the 4th dog even after administration port removal. Based on this pilot study, the SHUS warrants further clinical evaluation for treatment of dogs with USMI unresponsive to medical management.